Axcelis
ACLS
325 hedge funds and large institutions have $2.2B invested in Axcelis in 2022 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 86 increasing their positions, 121 reducing their positions, and 25 closing their positions.
176% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 25
167% more call options, than puts
Call options by funds: $16.7M | Put options by funds: $6.26M
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
28% more capital invested
Capital invested by funds: $1.72B → $2.2B (+$486M)
13% more funds holding
Funds holding: 287 → 325 (+38)
0.97% less ownership
Funds ownership: 85.91% → 84.94% (-0.97%)
29% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 121
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$72.2M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$31.7M |
| 3 |
SM
Senvest Management
New York
|
+$19.4M |
| 4 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
+$18.6M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$28.4M |
| 2 |
Primecap Management
Pasadena,
California
|
-$26.4M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$16.9M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$7.39M |
| 5 |
Goldman Sachs
New York
|
-$6.86M |
ACLS Hedge Fund Activity: Q4 2022 in Review
325 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Axcelis (ACLS) for Q4 2022, worth a combined $2.2B — up 28% from $1.72B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new ACLS positions and 25 closed out — a net gain of 44 holders — while 86 added to existing stakes and 121 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $72.2M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $28.4M.
- 325 institutional investors held Axcelis (ACLS) as of Q4 2022, up from 287 in Q3 2022.
- Funds reported $2.2B of Axcelis stock for Q4 2022, up 28% quarter-over-quarter.
- 69 funds opened new Axcelis positions in Q4 2022 and 25 closed out, a net change of +44 holders.
- The largest Axcelis buyer in Q4 2022 was Fidelity Investments, an estimated $72.2M added.
- The largest Axcelis seller in Q4 2022 was Manulife (Manufacturers Life Insurance), an estimated $28.4M sold.
Based on aggregated 13F filings for Q4 2022.